KIT and melanoma: It is well known that the VEGF and KIT are potential targets for alternative therapeutics in malignant melanoma, and they are recognized to play a pivotal role in the pathogenesis and metastasis of melanoma (Graells et al., 2004; Curtin et al., 2006).